Alfred Sandrock
Vermögen: 2 Mio $ am 31.05.2026
Vermögen: 2 Mio $ am 31.05.2026
Derzeit bekleidet Alfred W. Sandrock die Position des Executive Vice President-Research & Development bei Biogen, Inc. und Chief Medical Officer bei Biogen Idec, Inc. (North Carolina) (eine Tochtergesellschaft von Biogen, Inc.). Er ist außerdem im Vorstand von Disarm Therapeutics, Inc. und Vorsitzender der PhRMA Foundation, Mitglied der American Academy of Neurology und Professor an der Harvard Medical School. Alfred W. Sandrock erwarb einen Abschluss an der Harvard Medical School, einen Doktortitel an der Harvard University und einen Bachelor-Abschluss an der Stanford University.
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 02.04.2026 | 472 549 ( 0,78 % ) | 2 Mio $ | 31.05.2026 |
| Unternehmen | Position | Beginn |
|---|---|---|
| VOYAGER THERAPEUTICS, INC. | Vorstandsvorsitzender | 22.03.2022 |
Transition Bio, Inc.
Transition Bio, Inc. BiotechnologyHealth Technology Provides condensate technology for drug discovery and diagnostics | Direktor/Vorstandsmitglied | 01.02.2022 |
Verge Analytics, Inc.
Verge Analytics, Inc. BiotechnologyHealth Technology Provides biotechnology services | Direktor/Vorstandsmitglied | 08.02.2022 |
PhRMA Foundation
PhRMA Foundation Miscellaneous Commercial ServicesCommercial Services Engages in research and development of drugs | Vorsitzender | - |
Harvard Medical School
Harvard Medical School Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | - |
American Academy of Neurology
American Academy of Neurology Miscellaneous Commercial ServicesCommercial Services Operates a professional society which represents neurologists and neuroscientists | Corporate Officer/Principal | - |
Longwood Fund Management LLC
Longwood Fund Management LLC Investment ManagersFinance Longwood Fund invests in companies located in the United States. The firm focuses on the healthcare sector. It participates in early stage capital transactions. | Berater | - |
| Unternehmen | Position | Ende |
|---|---|---|
Atalanta Therapeutics, Inc.
Atalanta Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Develops RNA interference based therapeutics to treat neurodegenerative diseases | Direktor/Vorstandsmitglied | 01.09.2024 |
| BIOGEN INC. | Technik-/Wissenschafts-/F&E-Leiter | 31.12.2021 |
| ░░░░░░ ░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░░░ ░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░ ░░░░░░░░░ ░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
| Private Unternehmen | 16 |
|---|---|
Neurocrine Biosciences, Inc.
Neurocrine Biosciences, Inc. BiotechnologyHealth Technology Discovers, develops and commercializes treatments for neurological, neuroendocrine and neuropsychiatric disorders | Health Technology |
Biogen, Inc.
Biogen, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets therapies for neurological and neurodegenerative diseases | Health Technology |
FORUM Pharmaceuticals, Inc.
FORUM Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops therapeutics for central nervous system disorders | Health Technology |
Harvard University
Harvard University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Stanford University
Stanford University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Biogen Idec, Inc. (North Carolina)
Biogen Idec, Inc. (North Carolina) Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products | Health Technology |
American Academy of Neurology
American Academy of Neurology Miscellaneous Commercial ServicesCommercial Services Operates a professional society which represents neurologists and neuroscientists | Commercial Services |
Harvard Medical School
Harvard Medical School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Longwood Fund Management LLC
Longwood Fund Management LLC Investment ManagersFinance Longwood Fund invests in companies located in the United States. The firm focuses on the healthcare sector. It participates in early stage capital transactions. | Finance |
PhRMA Foundation
PhRMA Foundation Miscellaneous Commercial ServicesCommercial Services Engages in research and development of drugs | Commercial Services |
Voyager Therapeutics, Inc.
Voyager Therapeutics, Inc. BiotechnologyHealth Technology Develops gene therapies for fatal and debilitating diseases of the central nervous system | Health Technology |
Verge Analytics, Inc.
Verge Analytics, Inc. BiotechnologyHealth Technology Provides biotechnology services | Health Technology |
Praxis Precision Medicines, Inc.
Praxis Precision Medicines, Inc. Pharmaceuticals: MajorHealth Technology Operates as clinical-stage biopharmaceutical company which develops therapies for central nervous system disorders | Health Technology |
Disarm Therapeutics, Inc.
Disarm Therapeutics, Inc. BiotechnologyHealth Technology Develops therapeutics to treat patients with neurological diseases | Health Technology |
Atalanta Therapeutics, Inc.
Atalanta Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Develops RNA interference based therapeutics to treat neurodegenerative diseases | Commercial Services |
Transition Bio, Inc.
Transition Bio, Inc. BiotechnologyHealth Technology Provides condensate technology for drug discovery and diagnostics | Health Technology |
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen